2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one → 3-Iodo-4-oxo-4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine-2-carboxylic acid ethyl ester
반응식
[CH2:1]([O:3][C:4]([C:6]1[C:10]([I:11])=[C:9](C(OCC)=O)[N:8]([CH2:17][CH2:18][NH:19][C:20]([O:22]C(C)(C)C)=O)[N:7]=1)=[O:5])[CH3:2].O(CC1C=C2C(=O)NCCN2N=1)C1C=CC=CC=1>>[CH2:1]([O:3][C:4]([C:6]1[C:10]([I:11])=[C:9]2[C:20](=[O:22])[NH:19][CH2:18][CH2:17][N:8]2[N:7]=1)=[O:5])[CH3:2]참가 물질
3
실험 절차
The compound was prepared from 1-(2-tert-butoxycarbonylamino-ethyl)-4-iodo-1H-pyrazole-3,5-dicarboxylic acid diethyl ester using the method described in the preceding example 6 (2-phenoxymethyl-6,7-dihydro-5H-pyrazolo[1,5-a]pyrazin-4-one).
출처 및 근거
- ORD 기록
- ord-f9d2a0647c864c63a03c8efcf7c1629d
- 출처 데이터셋
- uspto-grants-2013_11
- 특허 번호
- US08592422B2
반응 노트
불러오는 중…